During the past decade, Seoul St.Mary's Hospital; Medical Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Seoul St.Mary's Hospital; Medical Oncology" are "B-Cell Lymphoma" (1 trials), "Gastric Cancer" (1 trials), "Multiple Myeloma" (1 trials), "Non-Hodgkin Lymphoma" (1 trials) and "Non-Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Seoul St.Mary's Hospital; Medical Oncology" in a lesser frequency.

Most popular intervention types in "Seoul St.Mary's Hospital; Medical Oncology" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Daratumumab/rHuPH20" (1 trials), "Docetaxel" (1 trials), "Rituximab" (1 trials) and "Taxane" (1 trials). Other intervention names were less common.

The vast majority of trials in "Seoul St.Mary's Hospital; Medical Oncology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Seoul St.Mary's Hospital; Medical Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Seoul St.Mary's Hospital; Medical Oncology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Seoul St.Mary's Hospital; Medical Oncology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".